CHICAGO -- Upfront laser trabeculoplasty significantly slowed glaucoma progression and vision loss as compared with eye drops, long-term follow-up from a large randomized trial showed. After 6 years ...

If the laser isn’t aimed properly, it can cause inflammation, macular swelling, scarring, or corneal changes, according to Dr Desai. And while the technology can be cost-prohibitive for some practices ...

Please provide your email address to receive an email when new articles are posted on . The safety and efficacy of selective laser trabeculoplasty was comparable to argon laser trabeculoplasty. Data ...

More than 70 million people worldwide suffer from glaucoma. Treatment options have traditionally included eye drops to reduce the fluid the eye produces or surgery to unclog the eye's drainage. But a ...

Please provide your email address to receive an email when new articles are posted on . Earlier this year, The Lancet published the results of the LiGHT trial, comparing selective laser ...

Laser treatment has the potential to transform the management of glaucoma in Africa, and to prevent more people from going irreversibly blind, particularly in regions with high disease prevalence and ...

YAVNE, Israel, May, 10, 2021 /PRNewswire/ -- BELKIN Laser, the Israel-based start-up bringing a fast, automated and non-invasive glaucoma laser treatment to market announced today that it has ...

Alcon has announced the US release of its Voyager direct selective laser trabeculoplasty (DSLT) platform, with a launch event scheduled for the American Glaucoma Society annual meeting later in ...

California-based medical technology startup ViaLase has announced that its ViaLase Laser device for glaucoma treatment has received CE mark approval. The approval moves the platform towards ...